BiCova Therapeutics, co-founded by Anthony Rullo and Robert Verhagen, develops Covalent Bifunctional Molecules (CBMs) to treat cancer and autoimmune diseases. Building on research from Rullo’s lab, BiCova’s platform offers an innovative approach where conventional biologics face challenges.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.